improving healthcare @OpenEvidence

San Francisco
Start of an amazing partnership between @MSKCancerCenter and @OpenEvidence to integrate the extensive genomic profiling on @OncoKB into OE. Also so good to see @TravisZack2 (My @ucsf internal medicine co-resident) and @SamyuktaMD (My MSK co-fellow) absolutely crushing it!
Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence. Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States. As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.
1
4
21
717
Vivien Ho retweeted
Huge news from @OpenEvidence. @MSKCancerCenter is one of the world's leading cancer centers, has partnered with @OpenEvidence to bring MSK's expertise to oncologists nationwide. An amazing example of where @OpenEvidence is having real world impact on cancer patients nationwide!
Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence. Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States. As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.
3
4
34
4,162
Vivien Ho retweeted
amazing work by Daniel Nadler and @OpenEvidence - using intelligence is going to help oncologists.
Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence. Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States. As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.
3
5
114
13,709
Vivien Ho retweeted
Big counterattack in the fight against cancer. Memorial Sloan Kettering is a gold standard for cutting edge cancer care. Now @OpenEvidence and MSK have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence!
Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence. Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States. As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.
9
4
148
14,723
Through a recent collaboration, Memorial Sloan Kettering Cancer Center (MSK) and @OpenEvidence are making precision oncology expertise more accessible within clinicians’ everyday workflows. The collaboration brings OpenEvidence and MSK's OncoKB™ knowledge base together to help deliver trusted, evidence-based guidance when and where it’s needed most. Watch to learn more ⬇️
4
14
57
3,886
Vivien Ho retweeted
MSK-caliber cancer diagnostics for every oncologist… very cool use of AI
Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence. Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States. As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.
5
2
73
7,859
Vivien Ho retweeted
Thank you to the @MSKCancerCenter for helping bring this collaboration to life 🧡🚀🚀
Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence. Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States. As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.
1
4
207
Vivien Ho retweeted
Exciting partnership that will save many, many lives.
Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence. Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States. As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.
1
1
112
Thank you to @MSKCancerCenter for being incredible partners with @OpenEvidence in our shared goal to end cancer for life.
Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence. Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States. As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.
3
17
1,086
Vivien Ho retweeted
Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence. Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States. As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.
27
59
316
377,061
Vivien Ho retweeted
Are you using @OpenEvidence? In @JAMA_current, Patel, @AnupamBJena et al show rapidly rising use with 271M queries from >950K clinicians spanning info treatment, management, diagnosis, & more. Our Editor's note discusses what AI platforms mean for education & clinical care jamanetwork.com/journals/jam…
3
15
57
5,183
Vivien Ho retweeted
Among US #clinicians, use of an #AI-enabled clinical information platform increased substantially over 2.5 years, with sustained use across #physician and nonphysician groups. Queries most often focused on #treatment and #management rather than #diagnosis, indicating that these tools are being used primarily to support #clinical decision-making at the point of care. ja.ma/4Ba9ej2
8
53
171
22,504
Vivien Ho retweeted
I’ve long felt that @OpenEvidence query data is the medical equivalent of the Google street view cameras, providing a first-hand look at how clinicians navigate the terrain of clinical knowledge, both knowns and unknowns. IMO there is so much utility in using these data to discover trends in our practice, holes in our guidelines, emerging clinical needs, opportunities for impact. But obviously, any mining of these data has to be approached with great care, for patient safety and clinician trust. This paper is a first measured step in publishing trends from OE data (other than implicitly through work with, eg society guidelines). It focuses on basic trends in who is using the platform and for what purpose. Excited to see it out. So much fun working with @TravisZack2 and our colleagues from Harvard on this. Other efforts are in the works and I hope there is much more to come in the genre of @OpenEvidence -> new evidence.
In @JAMA_current led by @vrpatel97, @IAmSamFin and @AnupamBJena: how are US 👨‍⚕️ actually using AI? We analyzed 271M queries from 950K+ clinicians on @OpenEvidence over 2.5 years. Monthly active users grew from 355 to 700K+, and 9/10 kept coming back. Link: jamanetwork.com/journals/jam…
6
10
89
10,478
LinkedIn's Top Startups list is built entirely from its own hiring data, so it measures one thing well: where people want to work. This year, OpenEvidence is #6 in the U.S. We're physicians and engineers working to organize and expand the world's collective medical knowledge, so no doctor has to practice without the best available evidence. If that's the work you want to do, we're hiring. linkedin.com/pulse/linkedin-…
8
1
122
19,813
Vivien Ho retweeted
LinkedIn's Top Startups list is built entirely from its own hiring data, so it measures one thing well: where people want to work. This year, OpenEvidence is #6 in the U.S. We're physicians and engineers working to organize and expand the world's collective medical knowledge, so no doctor has to practice without the best available evidence. If that's the work you want to do, we're hiring. linkedin.com/pulse/linkedin-…
3
4
39
22,702
Vivien Ho retweeted
Good people & an absolutely incredible product ➡️ the recipe for success 🚀 Thanks @AmbarMehta for all you do! We are thrilled to integrate @OpenEvidence into the content we develop @BehindTheKnife.
Extremely excited to share this collaboration between @OpenEvidence and @BehindTheKnife, with @georgoff and team. Exciting developments ahead!
1
3
16
1,874
Vivien Ho retweeted
The most influential clinical AI adjunct +++ ever made. Period. @OpenEvidence has transformed daily hospital workflows + surgical education into something entirely new. Thrilled to partner with the team building the future of medical knowledge ⚡️🔬
It happened. We got Behind the Knife. @BehindTheKnife's surgical education library will feed into OpenEvidence answers, and OpenEvidence will be built into their ABSITE and oral board prep. @AmbarMehta, a vascular surgeon who leads surgery initiatives at OpenEvidence, puts it this way: the toughest surgical decisions live between the lines of the evidence.
2
6
46
3,171
Vivien Ho retweeted
It happened. We got Behind the Knife. @BehindTheKnife's surgical education library will feed into OpenEvidence answers, and OpenEvidence will be built into their ABSITE and oral board prep. @AmbarMehta, a vascular surgeon who leads surgery initiatives at OpenEvidence, puts it this way: the toughest surgical decisions live between the lines of the evidence.
6
14
80
290,130
Vivien Ho retweeted
Really excited for the opportunity to work with Dr. Murray, Dr. Desai, Josh and the whole JHU team on projects around medical education and improved integration of clinical intelligence within workflows!
Johns Hopkins established the model for American medical education more than a century ago. Today @HopkinsMedicine and OpenEvidence announced a collaboration to define what that education should look like in the AI era, and to ground clinical care in the latest evidence. As AI learns to synthesize the world's medical knowledge in seconds, the clinician's role moves toward clinical judgment, first-principles reasoning, and the human work of caring for patients. The education model Johns Hopkins and OpenEvidence will design builds on those foundations, with a deeper grounding in pathophysiology and evidence-based medicine. Knowing why an ACE inhibitor works is understanding a physician carries through an entire career. Together we'll also build human-first AI that puts the best available evidence in the context of each patient's medical history and Johns Hopkins' best practices, so clinicians can reason through that information faster and make the best decision for their patient. Sanjay Desai, Vice Dean for Education at Johns Hopkins Medicine, says AI "invites us back to the bedside." For the educators here: which skills do you want every trainee to keep sharp?
2
7
979
Vivien Ho retweeted
At @NorthwesternMed, OpenEvidence now opens from inside Epic. This went live on October 8, and extended to nurses and pharmacists as well as physicians. “By making OpenEvidence available directly in the EHR, we’re giving clinicians a single, trusted source for evidence-based answers at the point of care. This collaboration reduces friction in clinical decision-making and allows our teams to stay focused on what matters most - caring for patients.” --James Adams, MD, CMO, Northwestern Medicine.
6
3
50
198,573